Verastem reported $-16808000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
AstraZeneca AZN:LN USD 2.29B 796M
Curis CRIS:US USD -11329000 1.96M
Cytokinetics CYTK:US USD -137380000 4.93M
Gilead Sciences GILD:US USD 2.52B 357M
Immunogen IMGN:US USD -57790000 19.96M
Novartis NOVN:VX USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Roche Holding ROG:VX 8.85B 3.26B
Tg Therapeutics TGTX:US USD -52994000 17.18M
Verastem VSTM:US USD -16808000 1.28M
YTE INCY:US USD 178.62M 401K
Ziopharm Oncology ZIOP:US USD -9159000 308K